cancer screening

Leveraging resources such as virtual data rooms and shared labs makes it easier for biotech startups to grow. This is good news: We need more companies attacking cancer from novel angles, including AI-enabled early detection. And who knows, maybe one of these will become a trillion-dollar company? — Anna Scaling early cancer detection Y Combinator’s newest request for startups (RFS) is well worth reading, and not just because it’s been a while since the incubator shared the ideas and categories its partners “would…

Image: Shutterstock (Shutterstock)A large, 10-year randomized trial has found that simply recommending a common screening procedure for colorectal cancer may not be as beneficial for the general public as hoped for. The study found no difference in cancer death rates between healthy middle-aged people who were or weren’t offered a colonoscopy, though those offered a colonoscopy did have a slightly lower risk of diagnosis. The findings don’t necessarily show that routine colonoscopies aren’t worthwhile, but they will…

Questions remain about how to interpret MCED test results. Only some blood tests can pinpoint which organ the cancer is actually in. Lab tests must be run on potentially cancerous tissue to confirm a diagnosis, but you can’t biopsy someone’s entire body. False positives remain an issue for the entire field of cancer screening, which, by design, involves sifting through mounds of healthy tests to find cancer. Galleri—the MCED furthest along the path to widespread use—incorrectly flagged 57 healthy blood samples as…